The cannibals ingredient CBD could potentially block COVID-19 infection.
A new study suggests that CBD, specifically derived from the cannabis sativa plant, can be used as a “potential preventative agent” for early COVID-19 infection and warrants further research.
A review of 1,212 U.S. patients prescribed an oral, high-purity CBD dose of 100 milligrams-per-milliliter showed they tested positive for COVID-19 at lower rates compared to matched control groups of patients who didn’t take CBD, according to the 33 researchers from the University of Chicago, University of Louisville, University of Illinois at Chicago and the National COVID Cohort Collaborative Consortium.
It prevented the virus from replicating in the cells, according to the study. Then, researchers gave mice CBD one week before infecting them with the virus and found that it “suppressed infection both in the lung and the nasal passages of mice,” the release said.
The research contributes to a growing body of studies that examines potential benefits the cannabis plant can have when it comes to COVID-19 infection.
Research from Oregon State University also found that two other cannabis sativa plant compounds – CBGA and CBDA – could prevent COVID-19 from infecting human kidney cells in a peer-reviewed laboratory study published earlier in January.